MICHAEL KRATHEN: Open Payments
NPI 1932376050 · NATICK, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 20 payments from 12 companies in 2025. Trend: 2023 $194 · 2024 $189 · 2025 $547
Food & beverage: $448Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $99 |
| ABBVIE INC. | 3 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $65 |
| UCB, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Janssen Biotech, Inc. | 1 | $36 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
Products named: DUPIXENT, Bimzelx, ILUMYA, SKYRIZI, Rhapsido, TREMFYA, VALCHLOR, Sotyktu.
Industry payments across MA — which companies pay providers there.
